MURELIX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MURELIX Trademark

Serial Number: 79287792 • Registration: 6405718

MURELIX is a trademark filed by ISR Immune System Regulation Holding AB on February 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ISR Immune System Regulation Holding AB (3 trademarks)

Rörstrandsgatan 58

Entity Type: 03

Trademark Details

Filing Date

February 7, 2020

Registration Date

July 6, 2021

Published for Opposition

April 20, 2021

Goods & Services

Scientific research in the medical, pharmaceutical and bacteriological fields; consultancy and information in the field of scientific research as it relates to the medical, pharmaceutical and bacteriological fields; packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of reports relating to pharmaceutical formulation studies, design and development of granulation technology and pharmaceutical table technology; consultancy and information in the field of granulation technology and pharmaceutical table technology

Information and advice provided on-line via computer networks or the Internet relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations, diseases and medical conditions and treatment, providing information relating to prevention, diagnosis and treatment of infectious diseases, and information and advice relating to diagnosis and treatment of diseases and medical disorders

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of viral and infectious diseases and pharmaceutical preparations for the treatment of immune dysfunction and pharmaceutical preparations for the treatment of human immunedeficiency virus

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 18, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 23, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 2, 2021 FICS
FINAL DISPOSITION PROCESSED
Nov 2, 2021 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2021 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 6, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 6, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 20, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 18, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 31, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 31, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 31, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 17, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 17, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 17, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 17, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2021 TROA
REFUSAL PROCESSED BY IB
Sep 12, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 23, 2020 MAFR
ASSIGNED TO EXAMINER
Jun 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 18, 2020 REPR